Skip to main content
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care
  • Subscribe
  • Log in
  • My Cart
  • Follow ada on Twitter
  • RSS
  • Visit ada on Facebook
Diabetes

Advanced Search

Main menu

  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
  • More from ADA
    • Diabetes Care
    • Clinical Diabetes
    • Diabetes Spectrum
    • ADA Standards of Medical Care in Diabetes
    • ADA Scientific Sessions Abstracts
    • BMJ Open Diabetes Research & Care

User menu

  • Subscribe
  • Log in
  • My Cart

Search

  • Advanced search
Diabetes
  • Home
  • Current
    • Current Issue
    • Online Ahead of Print
    • ADA Scientific Sessions Abstracts
  • Browse
    • By Topic
    • Issue Archive
    • Saved Searches
    • ADA Scientific Sessions Abstracts
    • Diabetes COVID-19 Article Collection
    • Diabetes Symposium 2020
  • Info
    • About the Journal
    • About the Editors
    • ADA Journal Policies
    • Instructions for Authors
    • Guidance for Reviewers
  • Reprints/Reuse
  • Advertising
  • Subscriptions
    • Individual Subscriptions
    • Institutional Subscriptions and Site Licenses
    • Access Institutional Usage Reports
    • Purchase Single Issues
  • Alerts
    • E­mail Alerts
    • RSS Feeds
  • Podcasts
    • Diabetes Core Update
    • Special Podcast Series: Therapeutic Inertia
    • Special Podcast Series: Influenza Podcasts
    • Special Podcast Series: SGLT2 Inhibitors
    • Special Podcast Series: COVID-19
  • Submit
    • Submit a Manuscript
    • Submit Cover Art
    • ADA Journal Policies
    • Instructions for Authors
    • ADA Peer Review
Poster Presentations: Integrated Physiology/Obesity

2087-P: Association between L-FABP with Lipid Metabolism and Alteration after Laparoscopic Sleeve Gastrectomy in Chinese Obese Subjects

  1. HUI YOU,
  2. ZIWEI LIN,
  3. CUILING ZHU,
  4. XIN WEN,
  5. MANNA ZHANG and
  6. SHEN QU
  1. Shanghai, China
Diabetes 2019 Jun; 68(Supplement 1): -. https://doi.org/10.2337/db19-2087-P
Previous
  • Article
  • Info & Metrics
Loading

Abstract

Liver fatty acid-binding protein (FABP1) is associated with intracellular transportation of fatty acids. However, only few studies indicated the relationship between serum FABP1 and metabolism. This study aimed to investigate the association of FABP1 levels and metabolism factors, and its change with laparoscopic sleeve gastrectomy (LSG) in Chinese. The cross-sectional analysis included a total of 187 subjects, of which 65 were with normal weight (BMI 18-24 kg/m2), 59 with over weight (BMI25-27 kg/m2), and 64 with obesity (BMI≥28 kg/m2). We found FABP1 levels in obese (303±235pg/ml, p<0.05) and over-weight (189±187pg/ml, p<0.07) subjects were significantly higher than those in normal-weight subjects (142±93pg/ml), and higher in NAFLD (225±220pg/ml, p< 0.01) than in those without (129±74pg/ml) as well. In order to further investigated the correlation between FABP1 and metabolic factors, we performed a linear-regression analysis. We found FABP1 was positively correlated with BMI (R2=0.201, p<0.001), ALT(R2=0.324, p<0.001), AST(R2=0.387, p<0.001), m-AST(R2=0.160, p<0.001),[[γ]]-GT(R2=0.106, p<0.001), DBIL(R2=0.078, p= 0.001), UA(R2 =0.111, p<0.001), FBG(R2=0.066, p<0.001), LDL(R2 =0.042, p=0.005) and negatively correlated with HDL(R2 =0.051, p= 0.002). Moreover, we also enrolled 25 severely obese patients who underwent LSG to observe its effects on FABP1. We found with the decline of BMI after surgery, FABP1(294±211pg/ml) were also gradient decreased at 3-month (230±227pg/ml, p=0.463), 6-month (144±154pg/ml, p=0.09) and 12-month (115±32pg/ml, p=0.045).

In conclusion, serum FABP1 were correlated with obesity and NAFLD, and it might be an important mediator participating in metabolism disorders.

Disclosure H. You: None. Z. Lin: None. C. Zhu: None. X. Wen: None. M. Zhang: None. S. Qu: None.

Funding National Key Research and Development Program of China (2018YFC1314101); National Natural Science Foundation of China (81700752, 81500687)

  • © 2019 by the American Diabetes Association.
http://www.diabetesjournals.org/content/license

Readers may use this article as long as the work is properly cited, the use is educational and not for profit, and the work is not altered. More information is available at http://www.diabetesjournals.org/content/license.

Previous
Back to top
Diabetes: 68 (Supplement 1)

In this Issue

June 2019, 68(Supplement 1)
  • Table of Contents
  • Index by Author
Sign up to receive current issue alerts
View Selected Citations (0)
Article Alerts
Sign In to Email Alerts with your Email Address
Email Article

Thank you for your interest in spreading the word about Diabetes.

NOTE: We only request your email address so that the person you are recommending the page to knows that you wanted them to see it, and that it is not junk mail. We do not capture any email address.

Enter multiple addresses on separate lines or separate them with commas.
2087-P: Association between L-FABP with Lipid Metabolism and Alteration after Laparoscopic Sleeve Gastrectomy in Chinese Obese Subjects
(Your Name) has forwarded a page to you from Diabetes
(Your Name) thought you would like to see this page from the Diabetes web site.
CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.
Citation Tools
2087-P: Association between L-FABP with Lipid Metabolism and Alteration after Laparoscopic Sleeve Gastrectomy in Chinese Obese Subjects
HUI YOU, ZIWEI LIN, CUILING ZHU, XIN WEN, MANNA ZHANG, SHEN QU
Diabetes Jun 2019, 68 (Supplement 1) 2087-P; DOI: 10.2337/db19-2087-P

Citation Manager Formats

  • BibTeX
  • Bookends
  • EasyBib
  • EndNote (tagged)
  • EndNote 8 (xml)
  • Medlars
  • Mendeley
  • Papers
  • RefWorks Tagged
  • Ref Manager
  • RIS
  • Zotero
Add to Selected Citations
Share

2087-P: Association between L-FABP with Lipid Metabolism and Alteration after Laparoscopic Sleeve Gastrectomy in Chinese Obese Subjects
HUI YOU, ZIWEI LIN, CUILING ZHU, XIN WEN, MANNA ZHANG, SHEN QU
Diabetes Jun 2019, 68 (Supplement 1) 2087-P; DOI: 10.2337/db19-2087-P
del.icio.us logo Digg logo Reddit logo Twitter logo CiteULike logo Facebook logo Google logo Mendeley logo
  • Tweet Widget
  • Facebook Like
  • Google Plus One

Jump to section

  • Article
  • Info & Metrics

Related Articles

Cited By...

More in this TOC Section

Poster Presentations: Integrated Physiology/Obesity

  • 1909-P: The Platelet-Derived Growth Factor a—An Additional Pathophysiological Factor in Hepatic Steatosis and Fibrosis Development Both in Patients with Hepatitis C and Patients with Prediabetes
  • 2013-P: Lifestyle Intervention, Metformin, and Acarbose Treatments Differentially Impact Liver Fat Content, Serum Lipids, and Hormone Profiles in Obese Polycystic Ovary Syndrome Patients with Impaired Glucose Tolerance
  • 2029-P: Role of Adipose Tissue Macrophage–Derived F13A1 in Regulating Preadipocyte Hyperplasia during Obesity
Show more Poster Presentations: Integrated Physiology/Obesity

P: Obesity—Human

  • 2010-P: Adipocyte Clusterin Is a Link between Cardiometabolism and Alzheimer’s Disease
  • 1992-P: Metabolic Factors Associated with Cognitive Function and Brain Morphology in Type 2 Diabetes
  • 1998-P: Waist Circumference Change in the First Year of the Look AHEAD Trial Is Associated with Risk for Cardiovascular Morbidity and Mortality
Show more P: Obesity—Human

Similar Articles

Navigate

  • Current Issue
  • Online Ahead of Print
  • Scientific Sessions Abstracts
  • Collections
  • Archives
  • Submit
  • Subscribe
  • Email Alerts
  • RSS Feeds

More Information

  • About the Journal
  • Instructions for Authors
  • Journal Policies
  • Reprints and Permissions
  • Advertising
  • Privacy Policy: ADA Journals
  • Copyright Notice/Public Access Policy
  • Contact Us

Other ADA Resources

  • Diabetes Care
  • Clinical Diabetes
  • Diabetes Spectrum
  • Scientific Sessions Abstracts
  • Standards of Medical Care in Diabetes
  • BMJ Open - Diabetes Research & Care
  • Professional Books
  • Diabetes Forecast

 

  • DiabetesJournals.org
  • Diabetes Core Update
  • ADA's DiabetesPro
  • ADA Member Directory
  • Diabetes.org

© 2021 by the American Diabetes Association. Diabetes Print ISSN: 0012-1797, Online ISSN: 1939-327X.